尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Pinion John Richard, 管理人员. Director active across 1 company, notably Ultragenyx Pharmaceutical Inc.. Aggregated, 9 reports have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €420k. History available since 6 May 2021. The latest transaction was disclosed on 16 April 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
John Richard Pinion is a key member of Ultragenyx Pharmaceutical Inc. While his specific role is not detailed, he contributes to the management and strategy of the company. His expertise in the pharmaceutical sector is essential for guiding strategic decisions and optimizing performance.